It has been reported that PYCARD hypermethylation was identified not only in prostate cancer but also in prostate cancer precursor lesions called high-grade prostatic intraepithelial neoplasia (HGPIN) [35, 37]. Here, PYCARD is linked to prostate carcinoma.